Skip to Content
MilliporeSigma

HPLC Analysis of Cinacalcet Hydrochloride Impurities with a Purospher® STAR Phenyl Column

HPLC Analysis of Cinacalcet Hydrochloride Impurities with a Purospher® STAR Phenyl Column

Materials

analytical column

Product No.
Description
Pricing

manu-CART NT cartridge holder for LiChroCART 2,3,4,4.6 mm i.d. HPLC cartridges

Purospher® STAR Phenyl (5 µm)

L × I.D. 150 mm x 4.6 mm LiChroCART HPLC cartridge, manuCART holder required for use

Purospher® STAR Phenyl (5 µm)

L × I.D. 150 mm x 4.6 mm Hibar® RT HPLC column

mobile phase component

Product No.
Description
Pricing

Perchloric acid

ACS reagent, 70%

Sodium perchlorate

ACS reagent, ≥98.0%

Water

HPLC Plus

Acetonitrile

gradient grade for liquid chromatography LiChrosolv® Reag. Ph Eur

Milli-Q® IQ 7003/05/10/15 Ultrapure and Pure Water Purification Systems

Produces ultrapure (Type 1) water and pure (Type 2) water with a production flow rate of 3 L/hr from tap water feed

standard

Product No.
Description
Pricing

Cinacalcet Related Compound C

United States Pharmacopeia (USP) Reference Standard

Cinacalcet hydrochloride

United States Pharmacopeia (USP) Reference Standard

Cinacalet Related Compound D

United States Pharmacopeia (USP) Reference Standard

CONDITIONS

column

Purospher® STAR Phenyl (5 µm) LiChroCART 150 x 4.6 mm I.D. (1.51922)

mobile phase

[A] 10 mmol/L Sodium perchlorate solution, adjusted to pH 2.5 with perchloric acid; [B] Acetonitrile

gradient

0-0.5 min 2.5% B, in 4.5 min to 95%B, 2 min 95%B, 3 min at 2.5%B

flow rate

1.0 mL/min

pressure

60 bar (870 psi)

column temp.

60°C (Sampler: 10 °C)

detector

UV, 215 nm (analytical flow cell; 10 µL)

injection

5 µL

sample/matrix

Impurity identification solution with cinacalcet impurities A, B, C at 1.5 µg/mL each and cinacalcet at 5 µg/mL in solvnt mixture (10 mmol/L sodium perchlorate solution, adjusted to pH 2.5 with perchloric acid, and acetonitrile in a ratio of 50:50 (%v/v))

Description

General description

Cinacalcet hydrochloride is an oral calcimimetic indicated for the treatment of secondary hyperthyroidism in patients on dialysis with end-stage renal disease, and in patients with parathyroid carcinoma to reduce hypercalcemia.

Analysis Note

The developed method on a Purospher® STAR Phenyl, 150 × 4.6 mm (5µm) column was found to be linear for cinacalcet hydrochloride up to a concentration of 6 µg/mL with a LOQ of 0.65 µg/mL and LOD of 0.21 µg/mL. For cinacalcet impurity A, impurity B and impurity C, the method was linear up to a concentration of 1.8 µg/mL with LOQ ranging from 0.03 to 0.13 µg/mL and LOD ranging from 0.01 to 0.04 µg/mL. The method can be applied for the study of related substances in cinacalcet hydrochloride API using the Purospher® STAR Phenyl HPLC column. Repeatability for the cinacalcet 5 µg/mL solution was 1.19% RSD (n=5). The tailing factor for cinacalcet eluting at 12.3 min was NMT 2.0 (1.31) and the theoretical plate count was significantly above 2000.

Other Notes

App_501

Legal Information

LICHROCART is a trademark of Merck KGaA, Darmstadt, Germany
Purospher is a registered trademark of Merck KGaA, Darmstadt, Germany